Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease
Table 2
Healthcare resources used for the identification of first CKD diagnosis.
Healthcare resources
CKD patients
= 1,989 (%)
CKD-related hospital discharge diagnoses*
1,151 (57.9)
Primary diagnosis
258 (13.0)
Secondary diagnosis
867 (43.6)
Procedures
39 (2.0)
CKD-related conditions as indication of use for drug prescriptions
838 (42.1)
Allopurinol
213 (10.7)
Furosemide
94 (4.7)
Polystyrene sulfonate
63 (3.2)
Calcitriol
56 (2.8)
Ramipril
29 (1.5)
Metformin and sulfonamides
28 (1.4)
Acetylsalicylic acid
24 (1.2)
Metformin
22 (1.1)
Electrolytes solutions
19 (1.0)
Glimepiride
16 (0.8)
Ferrous sulfate
12 (0.6)
Torasemide
12 (0.6)
Amlodipine
11 (0.6)
Simvastatin
10 (0.5)
Bisoprolol
9 (0.5)
Nebivolol
9 (0.5)
Losartan
9 (0.5)
Atorvastatin
9 (0.5)
Spironolactone
8 (0.4)
Ramipril plus diuretics
8 (0.4)
Others**
177 (33.2)
Categories of discharge diagnoses and procedures are not mutually exclusive as in some patients CKD-related discharge diagnosis and procedures may have been registered at the same time. Other drugs which account for less than 0.4% of first CKD diagnosis identification.